Biocompatibility: demonstrated biological safety of your materials.

We conduct your device's biological evaluation under the ISO 10993 series, prioritising a risk-based approach: material characterisation, toxicological assessment and a reasoned selection of the tests actually needed - avoiding unnecessary testing.

Biocompatibility: demonstrated biological safety of your materials.
What we deliver

We plan biocompatibility through risk assessment, rather than a blind checklist of tests.

  1. Biological Evaluation Plan (BEP) under ISO 10993-1.

  2. Chemical characterisation of materials and toxicological risk assessment.

  3. Definition of the testing matrix (cytotoxicity, sensitisation, irritation, etc.).

  4. Coordination of testing with qualified laboratories.

  5. Biological Evaluation Report (BER) integrated with risk management.

Deliverables

What you receive

A Biological Evaluation Plan (BEP).
Toxicological risk assessment and material characterisation.
A Biological Evaluation Report (BER).
Integration into the risk management file (ISO 14971).
References

Reference standards

  • ISO 10993-1 and other parts of the series (biological evaluation of devices).
  • ISO 14971 - risk management (integration of biological evaluation).
  • ANVISA, FDA and MDR biocompatibility requirements.
FAQ

Frequently asked questions

Let's talk

Does your device come into contact with the body?

We demonstrate biological safety under ISO 10993, without unnecessary testing.

Speak to a specialist

Or leave your details and we will get back to you:

We have received your details.

Our team will contact you shortly. Thank you!